Hologic

Source: www.marketwatch.com --- 18 days ago
...

Source: www.prnewswire.com --- 35 days ago
...

Source: www.moreover.com --- 24 days ago
KLFY Sep 16 2008 3:18PM GMT ...

Source: www.earthtimes.org --- 24 days ago
DUBLIN, Ireland - Research and Markets (http://www.researchandmarkets.com/research/9f8c6c/hologic_inc_medi) has announced the addition of the Hologic, Inc. Medical Equipment Company Share Analysis companyprofile to t ...

Source: www.streetinsider.com --- 11 days ago
Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/Collins+Stewart+Initiates+Coverage+on+Hologic+%28HOLX%29+with+a+Hold/4023437.html for the full story. ...

Source: www.fwicki.com --- 35 days ago
BEDFORD, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Morgan Stanley Global Healthcare Unplugged Conference being held September 9, 2008, at ... ...

Source: www.ncbi.nlm.nih.gov --- 16 days ago
Related Articles Patient satisfaction and quality of life after MammoSite breast brachytherapy. Am J Surg. 2008 Oct;196(4):545-8 Authors: Dragun AE, Harper JL, Taylor CE, Jenrette JM PURPOSE: To perform a satisfaction/quality-of-life (QOL) survey of patients undergoing MammoSite brachytherapy (MBT; Hologic, Inc, Marlborough, MA). METHODS: We asked patients 15 questions regarding treatment decision-making, and experience on-therapy/post-treatment. RESULTS: A total of 52 patients responded (median follow-up 30 months). Regarding decision-making, 5.8% viewed the avoidance of mastectomy as "not important." If MBT were not available, 55.8% would opt for whole-breast radiotherapy (WBRT) without difficulty, 28.8% would have significant travel/financial difficulty, and 15.4% would refuse radiotherapy/opt for mastectomy. Regarding choice factors, patients selected "focused therapy" (44.2%), "convenience" (36.5%), and "cutting edge" (17.3%). A total of 61.5% patients were not concerned about a second surgical procedure; 90.4% were not/somewhat concerned about infection. During treatment, 73.1% reported no pain/discomfort with catheter, 73.1% no wound difficulty, 51.0% no pain during removal, and 71.2% no pain post-treatment. A total of 98.1% of patients rated the experience good/excellent, 90.4% reported no/minor side effects, 92.3% rated cosmesis good/excellent, 98.1% were very/extremely likely to choose MBT again, and 100% would recommend MBT. ...

Source: www.marketwatch.com --- 18 days ago
LONDON (MarketWatch) -- The Nasdaq OMX 100, an index composed of stocks listed on the Nasdaq's U.S. and Scandinavian exchanges, announced eight changes. New entrants include the CME Group , CA Inc. , Fastenal , Joy Global , Linear Technology , Xilinx , Sigma-Aldrich and Altera . Exiting are Expedia , Hologic , Kaupthing, KLA-Tencor , Metso , Neste Oil , Skanska and Verisign . ...

Source: www.prnewswire.com --- 71 days ago
...

Source: www.prnewswire.com --- 78 days ago
...

Source: seekingalpha.com --- 70 days ago
Hologic Inc. (HOLX) F3Q08 (Qtr End 06/28/08) Earnings Call Complete Story » ...

Source: www.madison.com --- 77 days ago
Bedford, Mass.-based Hologic on Thursday announced that it has completed its acquisition of Third Wave Technologies, removing the Madison-based genetic technology company from Nasdaq at its close on Thursday. ...

Source: www.primenewswire.com --- 49 days ago
ALISO VIEJO, Calif., Aug. 22, 2008 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that Hologic and SenoRx have agreed jointly to request that the United States District Court for the Northern District of California resume proceedings in the lawsuit pending between the parties, including rescheduling the Markman claims construction hearing. The Court had previously granted a joint request by the parties to stay all proceedings in the case, including the Markman claims construction hearing (previously scheduled for June 25, 2008) and trial (previously scheduled to begin on July 14, 2008), for at least sixty days in order to provide the parties time to discuss possible resolution of the matter. ...

Source: www.streetinsider.com --- 62 days ago
Visit StreetInsider.com at http://www.streetinsider.com/Insider+Trades/Hologic+%28HOLX%29+Sees+Insider+Buying+from+CEO+and+President./3892360.html for the full story. ...

Source: www.streetinsider.com --- 85 days ago
Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Hologic+%28HOLX%29+Accepts+Shares+of+Third+Wave+Technologies+%28TWTI%29/3827066.html for the full story. ...

Source: www.fwicki.com --- 62 days ago
BEDFORD, Mass., Aug. 7 /PRNewswire-FirstCall/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Canaccord Adams 28th Annual Global Growth Conference being held August 12 - 14, 2008, at ... ...

Source: www.fastmoneystockpicks.com --- 23 days ago
Fast Money Stock Picks - September 12, 2008 - Retail and Financials Macke: UUP - PowerShares DB US Dollar Index Bullish - Sell GM - General Motors - Buy - Final Trade Najarian: HD - Home Depot - Buy LOW - Lowe’s - Buy HOLX - Hologic - Buy - Final Trade Seymour: EEM - iShares MSCI Emerging Markets Index ETF - Buy - [...] ...

Source: sergeyportman.blogspot.com --- 80 days ago
BEDFORD, Mass., July 21 /PRNewswire-FirstCall/ -- Hologic, Inc. , a diversified medical technologies company specializing in diagnostic tools, imaging products and interventional devices dedicated to serving the healthcare needs of women, today announced plans to release its third quarter fiscal 2008 operating results on Wednesday, July 30, 2008 after market close. In conjunction with the release, management will host a conference call on Thursday, July 31, 2008 at 9:00 a.m. (eastern). Interested participants may listen to the call by dialing 877-874-1589 or 719-325-4839 for international callers and referencing code 8448474 approximately 15 minutes prior to the call on July 31st. For those unable to participate in the live broadcast, a replay will be available one hour after the call ends through August 8, 2008 at 888-203-1112 or 719-457-0820 for international callers, access code 8448474. The Company will also provide a live webcast of the call. Interested participants may access the webcast at the Company's website at http://www.Hologic.com/ . A replay of the call will be archived on the Company's website. Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic leads the industry in digital mammography systems and offers the most advanced technology for breast imaging and breast biopsy. Hologic's c ...